Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Patients with acute ischemic stroke
- Patients with fire-heat syndrome
- Stroke onset within 48 hours
- NIHSS scores range from 5 points to 25 points
- Age from forty to eighty,gender not limited
- Informed and signed the consent

Exclusion Criteria

- Cardiogenic cerebral embolism,stroke caused by other reasons or the unexplained
- Patients suitable for thrombolytic therapy(rt-PA,urokinase),or have recieved thrombolytic therapy
- Patients suitable for endovascular therapy,or have recieved endovascular therapy
- Patients with serious disease of heart,lungs,liver or kidneys(The value of ALT or AST is more than 2 times of the upper limit of normal range,the value of creatinine is more than 1.5 times of the upper limit of normal range,asthma or COPD,or cardiac function level 4)
- Patients with bleeding or bleeding tendency recently
- Pregnant or lactating women
- Pre-existing limb dysfunction, psychiatric diaseses,or cognitive dysfunction that could confound the study results
- Patients with allergic constitutions,or have the contraindication of Ixeris of sonchifolia Hance components(KDZ injection) or Panax notoginseng saponins components(Xueshuantong injection)
- Patients have participated in other clinical trials within 3 months